Oncology Department of Tianjin Xiqing Hospital provides high-quality diagnosis and treatment services for Xiqing people

[ad_1]

　　Since its opening on July 1, 2022, the Oncology Department of Tianjin Xiqing Hospital, with the strong support of the hospital’s party and government leaders and related departments, has always adhered to the principle of “patient first, hospital first, discipline first, and safety first”. The principle of “first”, adhering to the treatment concept of “people-oriented, coexistence of human and tumor”, based on TCM syndrome differentiation and treatment, combined with modern treatment technology to provide personalized treatment for malignant tumors and their complications. Over the past six months, the Oncology Department of Integrated Traditional Chinese and Western Medicine has gradually carried out clinical work in outpatient clinics and wards, implemented multiple treatment programs, and gradually improved related procedures to provide high-quality medical services for the people of Xiqing.

　　Diagnosis and treatment features and conditions:

　　1. Outpatient diagnosis and treatment:The clinic will be officially opened on July 1, 2022. Chief Physician Fang Wenyan’s TCM Syndrome Differentiation and Treatment Outpatient Clinic will be set up on Monday and Friday mornings, and then Deputy Chief Physician Pei Zhijie’s Clinic will be gradually added on Wednesday mornings. In the outpatient clinic, oral targeted drug therapy and oral chemotherapy drugs were carried out on the basis of TCM syndrome differentiation and treatment. A total of 1,568 patients were treated within half a year. The results were satisfactory and were recognized by the general public. And set up a sarcoidosis outpatient clinic to conduct risk assessment and differential diagnosis for pulmonary nodules, liver nodules, thyroid nodules, breast nodules, superficial lymph node enlargement, etc. Imaging follow-up review of patients with sarcoidosis.

　　Second, ward diagnosis and treatment:While our department fully participates in clinical work such as daily management of patients and on duty, it also participates in out-of-home work such as screenings and physical examinations organized by the hospital. Within half a year, a total of 92 people were discharged from the departments and wards, involving tumors, cerebrovascular diseases, cardiovascular diseases, respiratory system and digestive system diseases. Among them, there were 63 cancer patients, including lung cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, glioma, kidney cancer, lymphoma, and maxillofacial tumors.PlaceThere are admitted patientsIntegrative traditional Chinese and Western medicine, inmiddleOn the basis of medical syndrome differentiation and treatment, give Chinese medicine decoction and Chinese medicine injection.forFor newly diagnosed patients or those in good general condition, a treatment plan will be formulated based on pathological results, genetic test results, clinical guidelines and diagnosis and treatment norms, including molecular targeted therapy, oral chemotherapy drugs, intravenous chemotherapy, local infusion chemotherapy, anti-bone metastasis and other anti-tumor treatments ; For patients in poor general condition or dying, the best supportive treatment is given to relieve pain and prolong survival. Can independently complete closed thoracic drainage, abdominal puncture and drainage, deep vein puncture, CT/B-ultrasound-guided puncture of multiple parts to obtain pathology (lymph nodes, pancreas, lungs, etc.) and other clinical operations.

　　3. Cancer pain standardization:Hospitalized patients undergo cancer pain assessment, analgesic drug titration, guide patients to apply for Maka, take medicine regularly, and prepare for the listing of standardized wards for later stage cancer pain.

　　4. The progress of the treatment project:

1. Plasma radiofrequency ablation: This technology is an important treatment method for benign and malignant nodules, especially for tiny nodules. At present, the project has been completed and can be put into use.

2. In vitro high-frequency hyperthermia technology: Tumor cells have a lower tolerance to temperature than normal tissue cells. Generally, tumor cells are killed at 43°C. In vitro high-frequency hyperthermia technology uses this difference to deep heat the patient’s body to make The heat source directly reaches the tumor body to kill tumor cells. Currently, the project is in progress.

3. Implantation of radioactive iodine 125 seeds: This technology is to implant radioactive particles into the tumor body to continuously kill tumor cells. The technology is mature. In the past 20 years and nearly 3000 cases of clinical application, excellent results have been obtained. curative effect. Currently, the project is in progress.

With the improvement of outpatient clinics and wards of the oncology department integrating traditional Chinese and Western medicine, and the successive development of treatment projects, Xiqing Hospital can provide rich treatment methods for patients with early, middle and advanced tumors, and provide high-quality and convenient diagnosis and treatment services for the people of Xiqing.

　　

[ad_2]

Source link